Location History:
- Abingdon, GB (2018)
- Oxon, GB (2020)
Company Filing History:
Years Active: 2018-2020
Title: The Innovative Contributions of Philip Lecane
Introduction
Philip Lecane is a notable inventor based in Oxon, GB. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Lecane's work focuses on targeted therapies that aim to suppress various forms of cancer.
Latest Patents
Lecane's latest patents include groundbreaking methods for cancer treatment. One of his inventions, titled "Suppression of prostate cancer using a targeted clostridial neurotoxin," relates to a method for suppressing or treating cancer, particularly colorectal, breast, prostate, and lung cancers. This therapy utilizes a non-cytotoxic protease that targets growth hormone-secreting cells, such as pituitary cells. When delivered, the protease is internalized, inhibiting the secretion and transmission of growth hormone from these cells. Another patent, "Suppression of cancer," involves polypeptides designed to suppress cancer and related disorders. This treatment also employs a non-cytotoxic protease targeted to cancer cells, which, upon delivery, is internalized to inhibit secretion from the cancer cells.
Career Highlights
Philip Lecane is currently associated with Ipsen Bioinnovation Limited, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from various types of cancer.
Collaborations
Lecane collaborates with esteemed colleagues, including Frederic Madec and Philip Marks, to further enhance the impact of his research and innovations in the field of oncology.
Conclusion
Philip Lecane's contributions to cancer treatment through his innovative patents highlight his dedication to improving patient outcomes. His work exemplifies the importance of targeted therapies in the fight against cancer.